- Home
- NNOX vs ABEO Comparison
NNOX vs ABEO Comparison
Compare NNOX & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- ABEO
- Stock Information
- Founded
- NNOX 2011
- ABEO 1974
- Country
- NNOX Israel
- ABEO United States
- Employees
- NNOX N/A
- ABEO N/A
- Industry
- NNOX Medical Electronics
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- ABEO Health Care
- Exchange
- NNOX Nasdaq
- ABEO Nasdaq
- Market Cap
- NNOX 253.8M
- ABEO 281.0M
- IPO Year
- NNOX 2020
- ABEO 1980
- Fundamental
- Price
- NNOX $3.88
- ABEO $5.23
- Analyst Decision
- NNOX Strong Buy
- ABEO Strong Buy
- Analyst Count
- NNOX 2
- ABEO 6
- Target Price
- NNOX $8.50
- ABEO $18.17
- AVG Volume (30 Days)
- NNOX 1.3M
- ABEO 1.0M
- Earning Date
- NNOX 11-20-2025
- ABEO 11-13-2025
- Dividend Yield
- NNOX N/A
- ABEO N/A
- EPS Growth
- NNOX N/A
- ABEO N/A
- EPS
- NNOX N/A
- ABEO 0.99
- Revenue
- NNOX $11,886,000.00
- ABEO $400,000.00
- Revenue This Year
- NNOX $20.50
- ABEO N/A
- Revenue Next Year
- NNOX $64.10
- ABEO $324.71
- P/E Ratio
- NNOX N/A
- ABEO $5.34
- Revenue Growth
- NNOX 17.36
- ABEO N/A
- 52 Week Low
- NNOX $3.60
- ABEO $3.93
- 52 Week High
- NNOX $11.00
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- NNOX 45.89
- ABEO 39.16
- Support Level
- NNOX $3.87
- ABEO $5.29
- Resistance Level
- NNOX $4.17
- ABEO $5.61
- Average True Range (ATR)
- NNOX 0.21
- ABEO 0.23
- MACD
- NNOX -0.02
- ABEO 0.02
- Stochastic Oscillator
- NNOX 10.77
- ABEO 3.89
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.